Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Human SERINC5 peptide (ab216440)

Key features and details

  • Purity: > 80% SDS-PAGE
  • Suitable for: Blocking

You may also be interested in

Product image
Human PF4 ELISA Kit (CXCL4) (ab100628)
Product image
APC Mouse IgG2a, monoclonal [MOPC-173] - isotype control (ab239461)
Anti-Lamin A antibody (ab2559)
Product image
APC/Cy7® Anti-Ly76 antibody [TER-119] (ab272262)

Description

  • Product name

    Human SERINC5 peptide
  • Purity

    > 80 % SDS-PAGE.

  • Animal free

    No
  • Nature

    Recombinant
    • Species

      Human

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Store at -20°C.

    pH: 7.4

Images

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-eIF3B antibody (ab40799)

  •  
  • Product image

    Anti-EIF3D antibody (ab220053)

  •  
  • Product image

    Human LAMTOR2 knockout HeLa cell line (ab265828)

  •  
  • Human IL-17 ELISPOT Kit (ab83723)

  •  
  • Product image

    Recombinant Human B9D2 protein (ab183172)

  •  
  • Product image

    Recombinant Human TULP1 protein (ab131704)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.